© 2020 RSM US LLP. All rights reserved.
Mitigating fraud and compliance risks in life sciences
Navigating risk and regulatory compliance
Today’s business environment can be a precarious place. Financial and operational risks have increased. Risk factors associated with accounting, regulatory compliance, information technology, operations and other areas can be difficult to manage. Without adequate protection, your finances, reputation and critical data are vulnerable.
And for many life sciences companies, given global operations and the frequent use of third parties, these risks are of particular concern, especially related to cybersecurity threats and noncompliance with regulations. For middle market life sciences companies, sound risk management policies and processes, Foreign Corrupt Practices Act and General Data Protection Regulation compliance measures and more are essential.
Patient support programs can become a risk to life sciences product manufacturers if used to gain preferential treatment for their products.
With the recent attention around speakers programs, ensure your life science organization has the proper controls in place to reduce risk.
This recent interview with Risk & Compliance magazine discusses the unique bribery and corruption risks life sciences organizations face.
Learn what the board and others who have executive oversight of life sciences companies need to understand about minimizing corruption risk.
The age of big data translates to even bigger risk for businesses of all sizes, but middle market companies are particularly vulnerable.
RSM has created a fraud awareness resource center to help organizations understand how to better prevent, detect and investigate fraud.
RSM recently gathered feedback from leading middle-market executives as part of its 2016 Global Corruption Law Compliance Survey.